Loading...
Non‐canonical cMet regulation by vimentin mediates Plk1 inhibitor–induced apoptosis
To address the need for improved systemic therapy for non–small‐cell lung cancer (NSCLC), we previously demonstrated that mesenchymal NSCLC was sensitive to polo‐like kinase (Plk1) inhibitors, but the mechanisms of resistance in epithelial NSCLC remain unknown. Here, we show that cMet was differenti...
Na minha lista:
| Udgivet i: | EMBO Mol Med |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6505578/ https://ncbi.nlm.nih.gov/pubmed/31040125 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.201809960 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|